E
Evogene Ltd.
EVGN
$1.05
$0.03933.89%
E
Sell
9/24/2024Downgrade
Evogene Ltd. (EVGN) was downgraded to E+ from D- on 9/24/2024 due to a decline in the valuation index, solvency index and total return index. Debt to equity increased from 0.07 to 0.18, and the quick ratio declined from 4.57 to 1.32.
Evogene Ltd. (EVGN) was downgraded to E+ from D- on 9/24/2024 due to a decline in the valuation index, solvency index and total return index. Debt to equity increased from 0.07 to 0.18, and the quick ratio declined from 4.57 to 1.32.
D
Sell
9/11/2024Upgraded
Evogene Ltd. (EVGN) was upgraded to D- from E+ on 9/11/2024 due to an increase in the volatility index.
Evogene Ltd. (EVGN) was upgraded to D- from E+ on 9/11/2024 due to an increase in the volatility index.
E
Sell
8/27/2024Downgrade
Evogene Ltd. (EVGN) was downgraded to E+ from D- on 8/27/2024 due to a decline in the volatility index.
Evogene Ltd. (EVGN) was downgraded to E+ from D- on 8/27/2024 due to a decline in the volatility index.
D
Sell
8/8/2024Upgraded
Evogene Ltd. (EVGN) was upgraded to D- from E+ on 8/8/2024 due to an increase in the valuation index and volatility index.
Evogene Ltd. (EVGN) was upgraded to D- from E+ on 8/8/2024 due to an increase in the valuation index and volatility index.
E
Sell
7/24/2024Downgrade
Evogene Ltd. (EVGN) was downgraded to E+ from D- on 7/24/2024 due to a decline in the valuation index, total return index and volatility index.
Evogene Ltd. (EVGN) was downgraded to E+ from D- on 7/24/2024 due to a decline in the valuation index, total return index and volatility index.
D
Sell
7/8/2024Upgraded
Evogene Ltd. (EVGN) was upgraded to D- from E+ on 7/8/2024 due to an increase in the volatility index.
Evogene Ltd. (EVGN) was upgraded to D- from E+ on 7/8/2024 due to an increase in the volatility index.
E
Sell
6/21/2024Downgrade
Evogene Ltd. (EVGN) was downgraded to E+ from D- on 6/21/2024 due to a decline in the growth index, volatility index and total return index.
Evogene Ltd. (EVGN) was downgraded to E+ from D- on 6/21/2024 due to a decline in the growth index, volatility index and total return index.
D
Sell
5/31/2024Upgraded
Evogene Ltd. (EVGN) was upgraded to D- from E+ on 5/31/2024 due to an increase in the volatility index and total return index.
Evogene Ltd. (EVGN) was upgraded to D- from E+ on 5/31/2024 due to an increase in the volatility index and total return index.
E
Sell
5/15/2024Downgrade
Evogene Ltd. (EVGN) was downgraded to E+ from D- on 5/15/2024 due to a substantial decline in the growth index, volatility index and solvency index. Total revenue declined 84.66% from $3.77M to $578, EBIT declined 82.36% from -$4.18M to -$7.63M, and earnings per share declined from -$0.0814 to -$0.1305.
Evogene Ltd. (EVGN) was downgraded to E+ from D- on 5/15/2024 due to a substantial decline in the growth index, volatility index and solvency index. Total revenue declined 84.66% from $3.77M to $578, EBIT declined 82.36% from -$4.18M to -$7.63M, and earnings per share declined from -$0.0814 to -$0.1305.
D
Sell
3/15/2024Upgraded
Evogene Ltd. (EVGN) was upgraded to D- from E+ on 3/15/2024 due to an increase in the volatility index and total return index.
Evogene Ltd. (EVGN) was upgraded to D- from E+ on 3/15/2024 due to an increase in the volatility index and total return index.
E
Sell
2/29/2024Downgrade
Evogene Ltd. (EVGN) was downgraded to E+ from D- on 2/29/2024 due to a decline in the volatility index.
Evogene Ltd. (EVGN) was downgraded to E+ from D- on 2/29/2024 due to a decline in the volatility index.
D
Sell
2/8/2024Upgraded
Evogene Ltd. (EVGN) was upgraded to D- from E+ on 2/8/2024 due to an increase in the volatility index and total return index.
Evogene Ltd. (EVGN) was upgraded to D- from E+ on 2/8/2024 due to an increase in the volatility index and total return index.
E
Sell
1/24/2024Downgrade
Evogene Ltd. (EVGN) was downgraded to E+ from D- on 1/24/2024 due to a decline in the volatility index.
Evogene Ltd. (EVGN) was downgraded to E+ from D- on 1/24/2024 due to a decline in the volatility index.
D
Sell
12/11/2023Upgraded
Evogene Ltd. (EVGN) was upgraded to D- from E+ on 12/11/2023 due to an increase in the volatility index and total return index.
Evogene Ltd. (EVGN) was upgraded to D- from E+ on 12/11/2023 due to an increase in the volatility index and total return index.
E
Sell
11/24/2023Downgrade
Evogene Ltd. (EVGN) was downgraded to E+ from D- on 11/24/2023 due to a decline in the total return index and volatility index.
Evogene Ltd. (EVGN) was downgraded to E+ from D- on 11/24/2023 due to a decline in the total return index and volatility index.
D
Sell
10/27/2023Upgraded
Evogene Ltd. (EVGN) was upgraded to D- from E+ on 10/27/2023 due to an increase in the volatility index.
Evogene Ltd. (EVGN) was upgraded to D- from E+ on 10/27/2023 due to an increase in the volatility index.
E
Sell
10/12/2023Downgrade
Evogene Ltd. (EVGN) was downgraded to E+ from D- on 10/12/2023 due to a decline in the growth index, volatility index and solvency index. Earnings per share declined from -$0.0727 to -$0.1686, operating cash flow declined 125.56% from -$2.26M to -$5.09M, and EBIT declined 108.91% from -$3.78M to -$7.9M.
Evogene Ltd. (EVGN) was downgraded to E+ from D- on 10/12/2023 due to a decline in the growth index, volatility index and solvency index. Earnings per share declined from -$0.0727 to -$0.1686, operating cash flow declined 125.56% from -$2.26M to -$5.09M, and EBIT declined 108.91% from -$3.78M to -$7.9M.
D
Sell
3/14/2023Downgrade
Evogene Ltd. (EVGN) was downgraded to D- from D on 03/14/2023.
Evogene Ltd. (EVGN) was downgraded to D- from D on 03/14/2023.
D
Sell
2/23/2023Upgraded
Evogene Ltd. (EVGN) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index and volatility index.
Evogene Ltd. (EVGN) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index and volatility index.
D
Sell
2/8/2023Downgrade
Evogene Ltd. (EVGN) was downgraded to D- from D on 2/8/2023 due to a decline in the total return index, solvency index and growth index. Earnings per share declined from -$0.179 to -$0.2141, and the quick ratio declined from 8 to 6.78.
Evogene Ltd. (EVGN) was downgraded to D- from D on 2/8/2023 due to a decline in the total return index, solvency index and growth index. Earnings per share declined from -$0.179 to -$0.2141, and the quick ratio declined from 8 to 6.78.
D
Sell
5/5/2022Upgraded
Evogene Ltd. (EVGN) was upgraded to D from D- on 5/5/2022 due to an increase in the volatility index, growth index and total return index.
Evogene Ltd. (EVGN) was upgraded to D from D- on 5/5/2022 due to an increase in the volatility index, growth index and total return index.
D
Sell
4/20/2022Downgrade
Evogene Ltd. (EVGN) was downgraded to D- from D on 4/20/2022 due to a large decline in the solvency index, total return index and growth index. Debt to equity increased from 0.01 to 0.02, the quick ratio declined from 12.74 to 8, and operating cash flow declined 31.74% from -$6.14M to -$8.08M.
Evogene Ltd. (EVGN) was downgraded to D- from D on 4/20/2022 due to a large decline in the solvency index, total return index and growth index. Debt to equity increased from 0.01 to 0.02, the quick ratio declined from 12.74 to 8, and operating cash flow declined 31.74% from -$6.14M to -$8.08M.
D
Sell
11/23/2021Upgraded
Evogene Ltd. (EVGN) was upgraded to D from D- on 11/23/2021 due to an increase in the growth index and valuation index.
Evogene Ltd. (EVGN) was upgraded to D from D- on 11/23/2021 due to an increase in the growth index and valuation index.
D
Sell
11/8/2021Downgrade
Evogene Ltd. (EVGN) was downgraded to D- from D on 11/8/2021 due to a decline in the volatility index and valuation index.
Evogene Ltd. (EVGN) was downgraded to D- from D on 11/8/2021 due to a decline in the volatility index and valuation index.
D
Sell
7/21/2021Downgrade
Evogene Ltd. (EVGN) was downgraded to D from D+ on 7/21/2021 due to a decline in the total return index, growth index and volatility index.
Evogene Ltd. (EVGN) was downgraded to D from D+ on 7/21/2021 due to a decline in the total return index, growth index and volatility index.
D
Sell
4/20/2021Upgraded
Evogene Ltd. (EVGN) was upgraded to D+ from D on 4/20/2021 due to an increase in the valuation index and volatility index.
Evogene Ltd. (EVGN) was upgraded to D+ from D on 4/20/2021 due to an increase in the valuation index and volatility index.
D
Sell
4/5/2021Downgrade
Evogene Ltd. (EVGN) was downgraded to D from D+ on 4/5/2021 due to a noticeable decline in the growth index, total return index and valuation index. Operating cash flow declined 147.6% from -$2.78M to -$6.87M, earnings per share declined from -$0.1646 to -$0.2381, and EBIT declined 37.33% from -$5.23M to -$7.18M.
Evogene Ltd. (EVGN) was downgraded to D from D+ on 4/5/2021 due to a noticeable decline in the growth index, total return index and valuation index. Operating cash flow declined 147.6% from -$2.78M to -$6.87M, earnings per share declined from -$0.1646 to -$0.2381, and EBIT declined 37.33% from -$5.23M to -$7.18M.
D
Sell
3/10/2021Upgraded
Evogene Ltd. (EVGN) was upgraded to D+ from D on 3/10/2021 due to a large increase in the total return index, valuation index and volatility index.
Evogene Ltd. (EVGN) was upgraded to D+ from D on 3/10/2021 due to a large increase in the total return index, valuation index and volatility index.
D
Sell
1/21/2021Downgrade
Evogene Ltd. (EVGN) was downgraded to D from D+ on 1/21/2021 due to a decline in the valuation index.
Evogene Ltd. (EVGN) was downgraded to D from D+ on 1/21/2021 due to a decline in the valuation index.
D
Sell
9/24/2020Upgraded
Evogene Ltd. (EVGN) was upgraded to D+ from D on 9/24/2020 due to a major increase in the growth index, volatility index and total return index. Total revenue increased 156.9% from $116 to $298, operating cash flow increased 42.89% from -$4.86M to -$2.78M, and earnings per share increased from -$0.236 to -$0.1646.
Evogene Ltd. (EVGN) was upgraded to D+ from D on 9/24/2020 due to a major increase in the growth index, volatility index and total return index. Total revenue increased 156.9% from $116 to $298, operating cash flow increased 42.89% from -$4.86M to -$2.78M, and earnings per share increased from -$0.236 to -$0.1646.
D
Sell
8/28/2020Upgraded
Evogene Ltd. (EVGN) was upgraded to D from D- on 8/28/2020 due to an increase in the volatility index, total return index and solvency index.
Evogene Ltd. (EVGN) was upgraded to D from D- on 8/28/2020 due to an increase in the volatility index, total return index and solvency index.
D
Sell
8/1/2019Upgraded
Evogene Ltd. (EVGN) was upgraded to D- from E+ on 8/1/2019 due to a substantial increase in the growth index and efficiency index. Net income increased 29.43% from -$5.8M to -$4.09M, earnings per share increased from -$0.2252 to -$0.16, and EBIT increased 10.71% from -$5.27M to -$4.7M.
Evogene Ltd. (EVGN) was upgraded to D- from E+ on 8/1/2019 due to a substantial increase in the growth index and efficiency index. Net income increased 29.43% from -$5.8M to -$4.09M, earnings per share increased from -$0.2252 to -$0.16, and EBIT increased 10.71% from -$5.27M to -$4.7M.
E
Sell
1/3/2019Downgrade
Evogene Ltd. (EVGN) was downgraded to E+ from D- on 1/3/2019 due to a decline in the efficiency index, volatility index and solvency index. Net income declined 23.89% from -$5.02M to -$6.22M, and total capital declined 7.5% from $75.01M to $69.38M.
Evogene Ltd. (EVGN) was downgraded to E+ from D- on 1/3/2019 due to a decline in the efficiency index, volatility index and solvency index. Net income declined 23.89% from -$5.02M to -$6.22M, and total capital declined 7.5% from $75.01M to $69.38M.
D
Sell
11/23/2016Downgrade
Evogene Ltd. (EVGN) was downgraded to D- from D on 11/23/2016 due to a large decline in the total return index, growth index and volatility index. Earnings per share declined from -$0.13 to -$0.2218, operating cash flow declined 69.06% from -$2.62M to -$4.42M, and EBIT declined 43.26% from -$3.78M to -$5.42M.
Evogene Ltd. (EVGN) was downgraded to D- from D on 11/23/2016 due to a large decline in the total return index, growth index and volatility index. Earnings per share declined from -$0.13 to -$0.2218, operating cash flow declined 69.06% from -$2.62M to -$4.42M, and EBIT declined 43.26% from -$3.78M to -$5.42M.
D
Sell
3/11/2016Downgrade
Evogene Ltd. (EVGN) was downgraded to D from D+ on 3/11/2016 due to a significant decline in the volatility index and total return index.
Evogene Ltd. (EVGN) was downgraded to D from D+ on 3/11/2016 due to a significant decline in the volatility index and total return index.
D
Sell
1/12/2016Downgrade
Evogene Ltd. (EVGN) was downgraded to D+ from C- on 1/12/2016 due to a decline in the total return index and valuation index.
Evogene Ltd. (EVGN) was downgraded to D+ from C- on 1/12/2016 due to a decline in the total return index and valuation index.
C
Hold
12/28/2015Upgraded
Evogene Ltd. (EVGN) was upgraded to C- from D+ on 12/28/2015 due to a major increase in the volatility index, growth index and valuation index.
Evogene Ltd. (EVGN) was upgraded to C- from D+ on 12/28/2015 due to a major increase in the volatility index, growth index and valuation index.
D
Sell
9/21/2015Downgrade
Evogene Ltd. (EVGN) was downgraded to D+ from C- on 9/21/2015 due to a substantial decline in the volatility index, total return index and growth index. Operating cash flow declined 22.75% from -$2.05M to -$1.58M, and total revenue declined 5.31% from $3.77M to $3.57M.
Evogene Ltd. (EVGN) was downgraded to D+ from C- on 9/21/2015 due to a substantial decline in the volatility index, total return index and growth index. Operating cash flow declined 22.75% from -$2.05M to -$1.58M, and total revenue declined 5.31% from $3.77M to $3.57M.
C
Hold
4/11/2014Upgraded
Evogene Ltd. (EVGN) was upgraded to C- from D+ on 4/11/2014 due to an increase in the valuation index, growth index and solvency index. The quick ratio increased from 6.11 to 15.08, earnings per share increased from -$0.1281 to -$0.2, and EBIT increased 44.15% from -$2.53M to -$3.64M.
Evogene Ltd. (EVGN) was upgraded to C- from D+ on 4/11/2014 due to an increase in the valuation index, growth index and solvency index. The quick ratio increased from 6.11 to 15.08, earnings per share increased from -$0.1281 to -$0.2, and EBIT increased 44.15% from -$2.53M to -$3.64M.
D
Sell
4/3/2014Downgrade
Evogene Ltd. (EVGN) was downgraded to D+ from C- on 4/3/2014 due to a noticeable decline in the growth index, valuation index and volatility index. Total revenue declined 1.95% from $4.32M to $4.23M.
Evogene Ltd. (EVGN) was downgraded to D+ from C- on 4/3/2014 due to a noticeable decline in the growth index, valuation index and volatility index. Total revenue declined 1.95% from $4.32M to $4.23M.
NASDAQ
04/11/2025 3:48PM Eastern
Quotes delayed
